AN INDEPENDENT PUBLIC HEALTH READING ROOM
Places. People.
Possibilities.

A Surrogate Endpoint Measures a Stand-In, So Keep the Patient Outcome in View

Paper collage of a notebook, tablet, magnifying glass and source card.
AI-created conceptual illustration of a fictional setting; not a record of people or outcomes.

A study can report a change in a laboratory marker without directly measuring whether participants live longer or feel better. The measured indicator may be useful, but the outcome named in the headline should match what the study actually assessed.

The National Cancer Institute explains that surrogate endpoints stand in for other outcomes and are not always reliable indicators of treatment benefit.

Make a two-column reading note

In the first column, write the endpoint measured by the study. In the second, write the patient outcome people may care about. Do not draw an automatic equals sign between them.

Then look for the researchers’ explanation of why the indicator is relevant in this particular setting. Evidence supporting a surrogate in one condition or treatment context should not be casually transferred to every other context.

A fictional example might report a favourable change in marker X after eight weeks. A careful summary preserves that statement instead of rewriting it as “prevents serious illness” when that outcome was not demonstrated.

This distinction is a research-reading tool, not advice to dismiss a test or alter care. Questions about how a marker informs an individual treatment decision belong with the clinician who understands the condition and the wider evidence.

Editorial illustration from this site’s image library; not documentary evidence of the example or object discussed.